{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:18:47Z","timestamp":1791901127800,"version":"4.3.4"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>We systematically reviewed and meta-analyzed the predictors of major adverse cardiac and cerebrovascular events (MACE\/MACCE) in older adults who underwent PCI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Three databases, PubMed, Embase, and Scopus, were searched for observational studies considering the out-of-hospital MACE\/MACCE in adults\u2009\u2265\u200960 years old with coronary artery disease (acute or chronic) who underwent PCI. Studies were eligible if they had determined at least two statistically significant predictors of MACE\/MACCE by multivariable analysis. We used the QUIPS tool to evaluate the risk of bias in the studies. Random-effects meta-analysis was utilized to pool the hazard ratios (HRs) of the most reported predictors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 34 studies were included in the review. Older age (HR\u2009=\u20091.04, 95% Confidence Interval (CI): 1.03\u20131.06, <jats:italic>P<\/jats:italic>-value\u2009&lt;\u20090.001), diabetes (HR\u2009=\u20091.36, 95% CI: 1.22\u20131.53, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), history of myocardial infarction (MI) (HR\u2009=\u20091.88, 95% CI: 1.37\u20132.57, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), ST-elevation MI (STEMI) at presentation (HR\u2009=\u20091.72, 95% CI: 1.37\u20132.18, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), reduced left ventricular ejection fraction (LVEF) (HR\u2009=\u20092.01, 95% CI: 1.52\u20132.65, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), successful PCI (HR\u2009=\u20090.35, 95% CI: 0.27\u20130.47, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), eGFR (HR\u2009=\u20090.99, 95% CI: 0.97-1.00; <jats:italic>P<\/jats:italic>-value\u2009=\u20090.04) and left main coronary artery (LMCA) disease (HR\u2009=\u20092.07, 95% CI: 1.52\u20132.84, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) were identified as predictors of MACE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We identified older age, diabetes, history of MI, STEMI presentation, lower LVEF, and LMCA disease increased the risk of MACE\/MACCE after PCI in older adults. Meanwhile, higher eGFR and successful PCI predicted lower adverse events risk. Future studies should focus on a more robust methodology and a precise definition of MACE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Registration<\/jats:title>\n                <jats:p>PROSPERO (CRD42023480332).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-024-04896-4","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T15:01:59Z","timestamp":1712934119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Predictors of major adverse cardiac and cerebrovascular events after percutaneous coronary intervention in older adults: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3225-8498","authenticated-orcid":false,"given":"Arash","family":"Jalali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0734-3888","authenticated-orcid":false,"given":"Ali","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5041-6798","authenticated-orcid":false,"given":"Mohammad Sadeq","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5914-9227","authenticated-orcid":false,"given":"Sepehr","family":"Nayebirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3579-4181","authenticated-orcid":false,"given":"Mohadese","family":"Dashtkoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6912-7788","authenticated-orcid":false,"given":"Zahra","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar","family":"Shafiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"key":"4896_CR1","doi-asserted-by":"publisher","first-page":"p8295054","DOI":"10.1155\/2019\/8295054","volume":"2019","author":"R Bauersachs","year":"2019","unstructured":"Bauersachs R, et al. Burden of Coronary Artery Disease and Peripheral Artery Disease: A literature review. Cardiovasc Ther. 2019;2019:p8295054.","journal-title":"Cardiovasc Ther"},{"issue":"18","key":"4896_CR2","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.jacc.2017.12.068","volume":"71","author":"MV Madhavan","year":"2018","unstructured":"Madhavan MV, et al. Coronary artery disease in patients\u2009\u2265\u200980 years of age. J Am Coll Cardiol. 2018;71(18):2015\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"4896_CR3","doi-asserted-by":"publisher","first-page":"16812","DOI":"10.1002\/jcp.28350","volume":"234","author":"AK Malakar","year":"2019","unstructured":"Malakar AK, et al. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019;234(10):16812\u201323.","journal-title":"J Cell Physiol"},{"issue":"2","key":"4896_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2991\/jegh.k.201217.001","volume":"11","author":"U Ralapanawa","year":"2021","unstructured":"Ralapanawa U, Sivakanesan R. Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: a narrative review. J Epidemiol Glob Health. 2021;11(2):169\u201377.","journal-title":"J Epidemiol Glob Health"},{"issue":"13","key":"4896_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.21037\/atm.2016.06.33","volume":"4","author":"F Sanchis-Gomar","year":"2016","unstructured":"Sanchis-Gomar F, et al. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256.","journal-title":"Ann Transl Med"},{"issue":"7","key":"4896_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/MCA.0000000000000765","volume":"30","author":"YM Su","year":"2019","unstructured":"Su YM, et al. Outcomes after percutaneous coronary intervention and comparison among scoring systems in predicting procedural success in elderly patients (\u2265\u200975 years) with chronic total occlusion. Coron Artery Dis. 2019;30(7):481\u20137.","journal-title":"Coron Artery Dis"},{"issue":"1","key":"4896_CR7","first-page":"40","volume":"7","author":"A Shafiee","year":"2012","unstructured":"Shafiee A, van Bodegom D. The necessity for research on the elderly in Iran. J Tehran Univ Heart Cent. 2012;7(1):40\u201340.","journal-title":"J Tehran Univ Heart Cent"},{"key":"4896_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fgene.2017.00216","volume":"8","author":"T Head","year":"2017","unstructured":"Head T, Daunert S, Goldschmidt-Clermont PJ. The aging risk and atherosclerosis: a Fresh look at arterial homeostasis. Front Genet. 2017;8:216.","journal-title":"Front Genet"},{"issue":"8","key":"4896_CR9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/MCA.0000000000000744","volume":"30","author":"H Sliman","year":"2019","unstructured":"Sliman H, et al. Clinical features and outcomes of revascularization in very old patients with left main coronary artery disease. Coron Artery Dis. 2019;30(8):584\u20139.","journal-title":"Coron Artery Dis"},{"issue":"3","key":"4896_CR10","doi-asserted-by":"publisher","first-page":"e014477","DOI":"10.1161\/JAHA.119.014477","volume":"9","author":"S Kumar","year":"2020","unstructured":"Kumar S, et al. Contemporary revascularization dilemmas in older adults. J Am Heart Assoc. 2020;9(3):e014477.","journal-title":"J Am Heart Assoc"},{"key":"4896_CR11","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"4896_CR12","unstructured":"UNHCR. Older persons. 2020 18 May 2020 29 November 2023]; Available from: https:\/\/emergency.unhcr.org\/protection\/persons-risk\/older-persons"},{"issue":"4","key":"4896_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA Hayden","year":"2013","unstructured":"Hayden JA, et al. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280\u20136.","journal-title":"Ann Intern Med"},{"key":"4896_CR14","unstructured":"Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.; Available from: https:\/\/www.R-project.org\/"},{"issue":"1","key":"4896_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12933-023-01794-8","volume":"22","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, et al. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22(1):75.","journal-title":"Cardiovasc Diabetol"},{"key":"4896_CR16","doi-asserted-by":"crossref","unstructured":"Li Q et al. Bivalirudin versus Heparin on net adverse clinical events, major adverse Cardiac and cerebral events, and bleeding in Elderly Chinese patients treated with percutaneous coronary intervention. Tohoku J Exp Med, 2023.","DOI":"10.1620\/tjem.2023.J085"},{"key":"4896_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.amjcard.2023.07.166","volume":"205","author":"A Marschall","year":"2023","unstructured":"Marschall A, et al. Outcomes prediction in Complex High-Risk indicated percutaneous coronary interventions in the older patients. Am J Cardiol. 2023;205:465\u201372.","journal-title":"Am J Cardiol"},{"key":"4896_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.amjcard.2023.07.094","volume":"204","author":"JI Park","year":"2023","unstructured":"Park JI, et al. Efficacy of percutaneous coronary intervention with synergy stents in patients aged\u2009\u2265\u200975 years: 1-Year clinical outcomes from the Synergy Elderly Registry. Am J Cardiol. 2023;204:43\u201352.","journal-title":"Am J Cardiol"},{"issue":"10","key":"4896_CR19","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00380-023-02276-3","volume":"38","author":"H Shimono","year":"2023","unstructured":"Shimono H, et al. Association of preoperative clinical frailty and clinical outcomes in elderly patients with stable coronary artery disease after percutaneous coronary intervention. Heart Vessels. 2023;38(10):1205\u201317.","journal-title":"Heart Vessels"},{"issue":"8","key":"4896_CR20","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.5551\/jat.64212","volume":"30","author":"K Yan","year":"2023","unstructured":"Yan K, et al. Five-year prognostic value of DAPT score in older patients undergoing percutaneous coronary intervention: a large-sample study in the Real World. J Atheroscler Thromb. 2023;30(8):1057\u201369.","journal-title":"J Atheroscler Thromb"},{"issue":"8","key":"4896_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.34172\/aim.2022.84","volume":"25","author":"A Fallahzadeh","year":"2022","unstructured":"Fallahzadeh A, et al. Outcome of percutaneous coronary intervention in old patients presenting with Acute Coronary Syndrome. Arch Iran Med. 2022;25(8):523\u201332.","journal-title":"Arch Iran Med"},{"issue":"18","key":"4896_CR22","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.2169\/internalmedicine.8932-21","volume":"61","author":"T Horikoshi","year":"2022","unstructured":"Horikoshi T, et al. A propensity score matched analysis of Statin effects on major adverse cardiac events after percutaneous coronary intervention in patients over 75 Years Old. Intern Med. 2022;61(18):2711\u20139.","journal-title":"Intern Med"},{"key":"4896_CR23","doi-asserted-by":"publisher","first-page":"943323","DOI":"10.3389\/fcvm.2022.943323","volume":"9","author":"J Lang","year":"2022","unstructured":"Lang J, et al. Staged revascularization vs. culprit-only percutaneous coronary intervention for multivessel disease in elderly patients with ST-segment elevation myocardial infarction. Front Cardiovasc Med. 2022;9:943323.","journal-title":"Front Cardiovasc Med"},{"key":"4896_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.amjcard.2022.06.030","volume":"180","author":"M Marino","year":"2022","unstructured":"Marino M, et al. Complete percutaneous revascularization in patients aged\u2009\u2265\u200985 years with Acute Coronary Syndrome and Multivessel Coronary Artery Disease. Am J Cardiol. 2022;180:10\u20136.","journal-title":"Am J Cardiol"},{"key":"4896_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ahj.2022.01.004","volume":"246","author":"K Otowa","year":"2022","unstructured":"Otowa K, et al. One-year outcome after percutaneous coronary intervention in nonagenarians: insights from the J-PCI OUTCOME registry. Am Heart J. 2022;246:105\u201316.","journal-title":"Am Heart J"},{"key":"4896_CR26","doi-asserted-by":"publisher","first-page":"p6210204","DOI":"10.1155\/2022\/6210204","volume":"2022","author":"J Wang","year":"2022","unstructured":"Wang J, et al. Impact of BMI on long-term outcomes in patients with ST-Segment Elevation myocardial infarction after primary percutaneous coronary intervention. Int J Clin Pract. 2022;2022:p6210204.","journal-title":"Int J Clin Pract"},{"key":"4896_CR27","doi-asserted-by":"publisher","first-page":"950165","DOI":"10.3389\/fcvm.2022.950165","volume":"9","author":"JL Wang","year":"2022","unstructured":"Wang JL, et al. Sex-related differences in clinical outcomes and predictive factors in the very elderly patients with ACS undergoing PCI. Front Cardiovasc Med. 2022;9:950165.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"4896_CR28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s40256-021-00468-8","volume":"21","author":"B Lattuca","year":"2021","unstructured":"Lattuca B, et al. Bleeding in the Elderly: risk factors and impact on clinical outcomes after an Acute Coronary Syndrome, a sub-study of the Randomized ANTARCTIC Trial. Am J Cardiovasc Drugs. 2021;21(6):681\u201391.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"2","key":"4896_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.hlc.2020.05.102","volume":"30","author":"M Lim","year":"2021","unstructured":"Lim M, et al. Clinical outcomes in older patients undergoing percutaneous coronary intervention for Non-ST-Elevation Acute Coronary syndromes. Heart Lung Circ. 2021;30(2):275\u201381.","journal-title":"Heart Lung Circ"},{"key":"4896_CR30","doi-asserted-by":"crossref","unstructured":"Kalyoncuo\u011flu M et al. Predicting one-year deaths and major adverse vascular events with the Controlling Nutritional Status score in Elderly patients with Non-ST-Elevated myocardial infarction undergoing percutaneous coronary intervention. J Clin Med, 2021. 10(11).","DOI":"10.3390\/jcm10112247"},{"issue":"6","key":"4896_CR31","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ehjqcco\/qcaa065","volume":"7","author":"A Kanwar","year":"2021","unstructured":"Kanwar A, et al. Poor quality of life in patients with and without frailty: co-prevalence and prognostic implications in patients undergoing percutaneous coronary interventions and cardiac catheterization. Eur Heart J Qual Care Clin Outcomes. 2021;7(6):591\u2013600.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"1","key":"4896_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00380-020-01659-0","volume":"36","author":"S Maruyama","year":"2021","unstructured":"Maruyama S, et al. Impact of nutritional index on long-term outcomes of elderly patients with coronary artery disease: sub-analysis of the SHINANO 5 year registry. Heart Vessels. 2021;36(1):7\u201313.","journal-title":"Heart Vessels"},{"issue":"4","key":"4896_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cjco.2020.03.005","volume":"2","author":"N Morici","year":"2020","unstructured":"Morici N, et al. Residual SYNTAX score and one-year outcome in Elderly patients with Acute Coronary Syndrome. CJC Open. 2020;2(4):236\u201343.","journal-title":"CJC Open"},{"issue":"33","key":"4896_CR34","doi-asserted-by":"publisher","first-page":"e20805","DOI":"10.1097\/MD.0000000000020805","volume":"99","author":"W Zhang","year":"2020","unstructured":"Zhang W, et al. Prognostic value of serum calprotectin level in elderly diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cohort study. Med (Baltim). 2020;99(33):e20805.","journal-title":"Med (Baltim)"},{"issue":"4","key":"4896_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.21037\/cdt.2018.12.04","volume":"9","author":"K Berezhnoi","year":"2019","unstructured":"Berezhnoi K, Kokov L, Vanyukov A. Effects of complete revascularization on long-term treatment outcomes in patients with multivessel coronary artery disease over 80 years of age admitted for acute coronary syndrome. Cardiovasc Diagn Ther. 2019;9(4):301\u20139.","journal-title":"Cardiovasc Diagn Ther"},{"key":"4896_CR36","doi-asserted-by":"publisher","first-page":"9690","DOI":"10.12659\/MSM.919802","volume":"25","author":"J Huang","year":"2019","unstructured":"Huang J, et al. Systemic Immune-Inflammatory Index predicts clinical outcomes for Elderly patients with Acute Myocardial Infarction receiving percutaneous coronary intervention. Med Sci Monit. 2019;25:9690\u2013701.","journal-title":"Med Sci Monit"},{"issue":"8","key":"4896_CR37","first-page":"344","volume":"21","author":"H Aghajani","year":"2018","unstructured":"Aghajani H, et al. Predictors of long-term major adverse cardiac events following percutaneous coronary intervention in the Elderly. Arch Iran Med. 2018;21(8):344\u20138.","journal-title":"Arch Iran Med"},{"issue":"5 Pt B","key":"4896_CR38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.carrev.2017.12.004","volume":"19","author":"JM de La Torre Hernandez","year":"2018","unstructured":"de La Torre Hernandez JM, et al. Multivessel disease in patients over 75years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI\u2009+\u200975 nation-wide registry. Cardiovasc Revasc Med. 2018;19(5 Pt B):580\u20138.","journal-title":"Cardiovasc Revasc Med"},{"key":"4896_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijcard.2018.01.057","volume":"259","author":"R De Rosa","year":"2018","unstructured":"De Rosa R, et al. High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - insight from the GEPRESS study. Int J Cardiol. 2018;259:20\u20135.","journal-title":"Int J Cardiol"},{"issue":"4","key":"4896_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/joic.12400","volume":"30","author":"RT Gerber","year":"2017","unstructured":"Gerber RT, et al. Age is not a bar to PCI: insights from the long-term outcomes from off-site PCI in a real-world setting. J Interv Cardiol. 2017;30(4):347\u201355.","journal-title":"J Interv Cardiol"},{"issue":"6","key":"4896_CR41","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1536\/ihj.15-420","volume":"57","author":"Z Wei","year":"2016","unstructured":"Wei Z, et al. Comparison of percutaneous coronary intervention Versus Coronary artery bypass graft in aged patients with unprotected left main artery lesions. Int Heart J. 2016;57(6):682\u20138.","journal-title":"Int Heart J"},{"issue":"9","key":"4896_CR42","first-page":"760","volume":"13","author":"XF Yu","year":"2016","unstructured":"Yu XF, et al. Staged versus one-time multivessel intervention in elderly patients with non-ST-elevation acute coronary syndrome. J Geriatr Cardiol. 2016;13(9):760\u20137.","journal-title":"J Geriatr Cardiol"},{"key":"4896_CR43","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ijcard.2014.11.012","volume":"179","author":"S Uthamalingam","year":"2015","unstructured":"Uthamalingam S, et al. Long term outcomes in octogenarians undergoing percutaneous coronary intervention: comparison of bare metal versus drug eluting stent. Int J Cardiol. 2015;179:385\u20139.","journal-title":"Int J Cardiol"},{"issue":"1","key":"4896_CR44","first-page":"16","volume":"10","author":"W Liu","year":"2013","unstructured":"Liu W, et al. Impact of diabetes on long term follow-up of elderly patients with chronic total occlusion post percutaneous coronary intervention. J Geriatr Cardiol. 2013;10(1):16\u201320.","journal-title":"J Geriatr Cardiol"},{"issue":"4","key":"4896_CR45","first-page":"336","volume":"9","author":"J Chen","year":"2012","unstructured":"Chen J, et al. Incomplete revascularization in the drug eluting stent era permits meaningful long-term (12\u201378 months) outcomes in patients\u2009\u2265\u200975 years with acute coronary syndrome. J Geriatr Cardiol. 2012;9(4):336\u201343.","journal-title":"J Geriatr Cardiol"},{"issue":"11","key":"4896_CR46","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/S0300-8932(09)73077-5","volume":"62","author":"R L\u00f3pez-Palop","year":"2009","unstructured":"L\u00f3pez-Palop R, et al. Safety and efficacy of coronary drug-eluting stents in octogenarians. Rev Esp Cardiol. 2009;62(11):1250\u20139.","journal-title":"Rev Esp Cardiol"},{"issue":"10","key":"4896_CR47","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00029330-200805020-00005","volume":"121","author":"HY Ma","year":"2008","unstructured":"Ma HY, et al. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent. Chin Med J (Engl). 2008;121(10):887\u201391.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"4896_CR48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2143\/AC.58.4.2005285","volume":"58","author":"O Gach","year":"2003","unstructured":"Gach O, et al. Predictors of early and late outcome of percutaneous coronary intervention in octogenarians. Acta Cardiol. 2003;58(4):289\u201394.","journal-title":"Acta Cardiol"},{"issue":"7","key":"4896_CR49","doi-asserted-by":"publisher","first-page":"E512","DOI":"10.1002\/ccd.27691","volume":"92","author":"E Rumiz","year":"2018","unstructured":"Rumiz E, et al. Long-term outcomes and predictors of morbi-mortality according to age in stemi patients with multivessel disease: impact of an incomplete revascularization. Catheter Cardiovasc Interv. 2018;92(7):E512\u20137.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"4896_CR50","first-page":"174","volume":"12","author":"VB Shanmugam","year":"2015","unstructured":"Shanmugam VB, et al. An overview of PCI in the very elderly. J Geriatr Cardiol. 2015;12(2):174\u201384.","journal-title":"J Geriatr Cardiol"},{"issue":"10","key":"4896_CR51","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1056\/NEJMoa2300468","volume":"389","author":"S Biscaglia","year":"2023","unstructured":"Biscaglia S, et al. Complete or culprit-only PCI in older patients with myocardial infarction. N Engl J Med. 2023;389(10):889\u201398.","journal-title":"N Engl J Med"},{"issue":"19","key":"4896_CR52","doi-asserted-by":"publisher","first-page":"e029057","DOI":"10.1161\/JAHA.122.029057","volume":"12","author":"JM Hanna","year":"2023","unstructured":"Hanna JM, et al. Complex percutaneous coronary intervention outcomes in older adults. J Am Heart Association. 2023;12(19):e029057.","journal-title":"J Am Heart Association"},{"issue":"2","key":"4896_CR53","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.pcad.2014.07.002","volume":"57","author":"JA Brenes-Salazar","year":"2014","unstructured":"Brenes-Salazar JA, Forman DE. Advances in Percutaneous Coronary interventions for Elderly patients. Prog Cardiovasc Dis. 2014;57(2):176\u201386.","journal-title":"Prog Cardiovasc Dis"},{"key":"4896_CR54","doi-asserted-by":"crossref","unstructured":"Nanna Michael G, et al. Assessment and Management of older adults undergoing PCI, part 1. Volume JACC. Advances; 2023. p. 100389. 4.","DOI":"10.1016\/j.jacadv.2023.100389"},{"issue":"5","key":"4896_CR55","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1540-8183.2006.00192.x","volume":"19","author":"KC Floyd","year":"2006","unstructured":"Floyd KC, et al. Age-based differences of percutaneous coronary intervention in the drug-eluting stent era. J Interv Cardiol. 2006;19(5):381\u20137.","journal-title":"J Interv Cardiol"},{"issue":"9","key":"4896_CR56","first-page":"574","volume":"15","author":"DW Kim","year":"2018","unstructured":"Kim DW, et al. Incremental age-related one-year MACCE after acute myocardial infarction in the drug-eluting stent era (from KAMIR-NIH registry). J Geriatr Cardiol. 2018;15(9):574\u201384.","journal-title":"J Geriatr Cardiol"},{"key":"4896_CR57","doi-asserted-by":"crossref","unstructured":"Kumar S et al. Sex-differences in outcomes after percutaneous coronary intervention of chronic total occlusions: insights from a large single-center registry. Eur Heart J, 2021.","DOI":"10.1093\/eurheartj\/ehab724.2786"},{"issue":"14","key":"4896_CR58","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.jacc.2020.01.056","volume":"75","author":"I Kosmidou","year":"2020","unstructured":"Kosmidou I, et al. Long-term outcomes in women and men following percutaneous coronary intervention. J Am Coll Cardiol. 2020;75(14):1631\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"4896_CR59","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.mayocp.2020.04.048","volume":"96","author":"M Alkhouli","year":"2021","unstructured":"Alkhouli M, et al. Age-stratified sex-related differences in the incidence, management, and outcomes of Acute myocardial infarction. Mayo Clin Proc. 2021;96(2):332\u201341.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"4896_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12916-021-02211-1","volume":"20","author":"E Tonet","year":"2022","unstructured":"Tonet E, et al. The impact of sex and physical performance on long-term mortality in older patients with myocardial infarction. BMC Med. 2022;20(1):15.","journal-title":"BMC Med"},{"issue":"5","key":"4896_CR61","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.clnu.2019.06.025","volume":"39","author":"E Tonet","year":"2020","unstructured":"Tonet E, et al. Nutritional status and all-cause mortality in older adults with acute coronary syndrome. Clin Nutr. 2020;39(5):1572\u20139.","journal-title":"Clin Nutr"},{"issue":"11","key":"4896_CR62","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1001\/jamainternmed.2014.4762","volume":"174","author":"SB Pancholy","year":"2014","unstructured":"Pancholy SB, et al. Sex differences in short-term and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: a meta-analysis. JAMA Intern Med. 2014;174(11):1822\u201330.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"4896_CR63","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/joic.12500","volume":"31","author":"N Xu","year":"2018","unstructured":"Xu N, et al. Sex-based differences in bleeding and long-term adverse events after percutaneous coronary intervention in older patients with coronary artery disease. J Interv Cardiol. 2018;31(3):345\u201352.","journal-title":"J Interv Cardiol"},{"issue":"13\u201314","key":"4896_CR64","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00508-016-0998-5","volume":"128","author":"T Weber","year":"2016","unstructured":"Weber T, et al. Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations: a joint scientific statement from the Austrian Society of Cardiology and the Austrian Society of Hypertension. Wien Klin Wochenschr. 2016;128(13\u201314):467\u201379.","journal-title":"Wien Klin Wochenschr"},{"issue":"47","key":"4896_CR65","doi-asserted-by":"publisher","first-page":"e2160","DOI":"10.1097\/MD.0000000000002160","volume":"94","author":"CY Wu","year":"2015","unstructured":"Wu CY, et al. High blood pressure and all-cause and Cardiovascular Disease mortalities in Community-Dwelling older adults. Med (Baltim). 2015;94(47):e2160.","journal-title":"Med (Baltim)"},{"issue":"1","key":"4896_CR66","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12872-022-02825-0","volume":"22","author":"S Dehdar Karsidani","year":"2022","unstructured":"Dehdar Karsidani S, et al. Intelligent prediction of major adverse cardiovascular events (MACCE) following percutaneous coronary intervention using ANFIS-PSO model. BMC Cardiovasc Disord. 2022;22(1):389.","journal-title":"BMC Cardiovasc Disord"},{"key":"4896_CR67","doi-asserted-by":"crossref","unstructured":"Zhao Y, Guo M, Shi G. Prediabetes predicts adverse cardiovascular outcomes after percutaneous coronary intervention: a meta-analysis. Biosci Rep, 2019. 40.","DOI":"10.1042\/BSR20193130"},{"key":"4896_CR68","doi-asserted-by":"crossref","unstructured":"Alzaky M, et al. Glycemic variability as a predictor of major adverse cardiac events after percutaneous coronary intervention. Volume 9. JOURNAL OF INDIAN COLLEGE OF CARDIOLOGY; 2019. pp. 148\u201353.","DOI":"10.4103\/JICC.JICC_9_19"},{"key":"4896_CR69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.carrev.2021.06.017","volume":"37","author":"A Latif","year":"2022","unstructured":"Latif A, et al. Impact of diabetes Mellitus on outcomes of Percutaneous Coronary intervention in chronic total occlusions: a systematic review and Meta-analysis. Cardiovasc Revasc Med. 2022;37:68\u201375.","journal-title":"Cardiovasc Revasc Med"},{"key":"4896_CR70","doi-asserted-by":"publisher","first-page":"907973","DOI":"10.3389\/fendo.2022.907973","volume":"13","author":"B Song","year":"2022","unstructured":"Song B, et al. Triglyceride glucose-body Mass Index and Risk of Incident Type 2 diabetes Mellitus in Japanese People with Normal Glycemic Level: a Population-based longitudinal cohort study. Front Endocrinol (Lausanne). 2022;13:907973.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4896_CR71","doi-asserted-by":"crossref","unstructured":"De Luca G et al. Impact of diabetes on clinical outcome among elderly patients with acute coronary syndrome treated with percutaneous coronary intervention: insights from the ELDERLY ACS 2 trial. J Cardiovasc Med, 2020.","DOI":"10.2459\/JCM.0000000000000978"},{"issue":"10","key":"4896_CR72","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1253\/circrep.CR-22-0048","volume":"4","author":"K Nishihira","year":"2022","unstructured":"Nishihira K, et al. Outcomes of Elderly patients with Acute myocardial infarction and heart failure who undergo percutaneous coronary intervention. Circ Rep. 2022;4(10):474\u201381.","journal-title":"Circ Rep"},{"issue":"5","key":"4896_CR73","doi-asserted-by":"publisher","first-page":"e011183","DOI":"10.1161\/JAHA.118.011017","volume":"8","author":"Y Numasawa","year":"2019","unstructured":"Numasawa Y, et al. Comparison of outcomes after percutaneous coronary intervention in Elderly patients, including 10 628 nonagenarians: insights from a Japanese Nationwide Registry (J-PCI Registry). J Am Heart Association. 2019;8(5):e011183.","journal-title":"J Am Heart Association"},{"issue":"5","key":"4896_CR74","doi-asserted-by":"publisher","first-page":"100442","DOI":"10.1016\/j.jscai.2022.100442","volume":"1","author":"M Saada","year":"2022","unstructured":"Saada M, et al. Prognosis of PCI in the older Adult Population: outcomes from the Multicenter prospective e-ULTIMASTER Registry. J Soc Cardiovasc Angiography Interventions. 2022;1(5):100442.","journal-title":"J Soc Cardiovasc Angiography Interventions"},{"issue":"7","key":"4896_CR75","doi-asserted-by":"publisher","first-page":"e058494","DOI":"10.1136\/bmjopen-2021-058494","volume":"12","author":"W Cuiping","year":"2022","unstructured":"Cuiping W, et al. Interactions of ST-elevation myocardial infarction, age, and sex and the risk of major adverse cardiovascular events among Chinese adults: a secondary analysis of a single-centre prospective cohort. BMJ Open. 2022;12(7):e058494.","journal-title":"BMJ Open"},{"key":"4896_CR76","doi-asserted-by":"publisher","first-page":"749072","DOI":"10.3389\/fcvm.2021.749072","volume":"8","author":"SS Chang","year":"2021","unstructured":"Chang SS, et al. Prognosis between ST-Elevation and Non-ST-elevation myocardial infarction in older adult patients. Front Cardiovasc Med. 2021;8:749072.","journal-title":"Front Cardiovasc Med"},{"key":"4896_CR77","first-page":"e011284","volume-title":"Change in left ventricular ejection Fraction with coronary artery revascularization and subsequent risk for adverse Cardiovascular outcomes","author":"RS Velagaleti","year":"2022","unstructured":"Velagaleti RS, et al. Change in left ventricular ejection Fraction with coronary artery revascularization and subsequent risk for adverse Cardiovascular outcomes. Volume 15. Circulation: Cardiovascular Interventions; 2022. p. e011284. 4."},{"issue":"44","key":"4896_CR78","doi-asserted-by":"publisher","first-page":"e31498","DOI":"10.1097\/MD.0000000000031498","volume":"101","author":"X Zhu","year":"2022","unstructured":"Zhu X, et al. Effect of glomerular filtration rate in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Med (Baltim). 2022;101(44):e31498.","journal-title":"Med (Baltim)"},{"issue":"3","key":"4896_CR79","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.archger.2010.01.007","volume":"51","author":"Q Chen","year":"2010","unstructured":"Chen Q, et al. Safety and effectiveness of percutaneous coronary intervention (PCI) in elderly patients. A 5-year consecutive study of 201 cases with PCI. Arch Gerontol Geriatr. 2010;51(3):312\u20136.","journal-title":"Arch Gerontol Geriatr"},{"issue":"2","key":"4896_CR80","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.19082\/6383","volume":"10","author":"H Farshidi","year":"2018","unstructured":"Farshidi H, et al. Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study. Electron Physician. 2018;10(2):6383.","journal-title":"Electron Physician"},{"issue":"2","key":"4896_CR81","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ahj.2013.05.006","volume":"166","author":"SV Rao","year":"2013","unstructured":"Rao SV, et al. Temporal trends in percutaneous coronary intervention outcomes among older patients in the United States. Am Heart J. 2013;166(2):273\u201381. e4.","journal-title":"Am Heart J"},{"issue":"2","key":"4896_CR82","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5603\/CJ.a2019.0109","volume":"28","author":"S Bae","year":"2021","unstructured":"Bae S, et al. Efficacy and safety of drug-eluting stents in elderly patients: a meta-analysis of randomized trials. Cardiol J. 2021;28(2):223\u201334.","journal-title":"Cardiol J"},{"issue":"10115","key":"4896_CR83","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0140-6736(17)32713-7","volume":"391","author":"O Varenne","year":"2018","unstructured":"Varenne O, et al. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet. 2018;391(10115):41\u201350.","journal-title":"Lancet"},{"issue":"4","key":"4896_CR84","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/joic.12215","volume":"28","author":"S Mitomo","year":"2015","unstructured":"Mitomo S, et al. Comparison between Plain Old Balloon Angioplasty and Drug-Eluting Stent Implantation for the treatment of Stent Fracture. J Interv Cardiol. 2015;28(4):365\u201373.","journal-title":"J Interv Cardiol"},{"issue":"5","key":"4896_CR85","first-page":"381","volume":"31","author":"CH Lai","year":"2015","unstructured":"Lai CH, et al. Comparison of Bare-Metal Stent and Drug-Eluting Stent for the treatment of patients undergoing percutaneous coronary intervention for unprotected left main coronary artery disease - long-term result from a single Center experience. Acta Cardiol Sin. 2015;31(5):381\u20139.","journal-title":"Acta Cardiol Sin"},{"issue":"2","key":"4896_CR86","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jacasi.2021.12.011","volume":"2","author":"S Park","year":"2022","unstructured":"Park S, Park SJ, Park DW. Percutaneous coronary intervention for Left Main Coronary Artery Disease: Present Status and Future perspectives. JACC Asia. 2022;2(2):119\u201338.","journal-title":"JACC Asia"},{"key":"4896_CR87","doi-asserted-by":"crossref","unstructured":"Tam Derrick Y, et al. Real-world examination of revascularization strategies for Left Main Coronary Disease in Ontario, Canada. Volume JACC. Cardiovascular Interventions; 2023. pp. 277\u201388. 3.","DOI":"10.1016\/j.jcin.2022.10.016"},{"issue":"10219","key":"4896_CR88","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0140-6736(19)32972-1","volume":"395","author":"NR Holm","year":"2020","unstructured":"Holm NR, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. Lancet. 2020;395(10219):191\u20139.","journal-title":"Lancet"},{"issue":"30","key":"4896_CR89","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1093\/eurheartj\/ehad369","volume":"44","author":"J Persson","year":"2023","unstructured":"Persson J, et al. PCI or CABG for left main coronary artery disease: the SWEDEHEART registry. Eur Heart J. 2023;44(30):2833\u201342.","journal-title":"Eur Heart J"},{"issue":"23 Pt A","key":"4896_CR90","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1016\/j.jacc.2018.09.012","volume":"72","author":"DW Park","year":"2018","unstructured":"Park DW, et al. 10-Year outcomes of stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease. J Am Coll Cardiol. 2018;72(23 Pt A):2813\u201322.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"4896_CR91","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","volume":"79","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, et al. 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice guidelines. J Am Coll Cardiol. 2022;79(2):e21\u2013129.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-04896-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-024-04896-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-04896-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T16:04:55Z","timestamp":1712937895000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-024-04896-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4896"],"URL":"https:\/\/doi.org\/10.1186\/s12877-024-04896-4","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,12]]},"assertion":[{"value":"1 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"337"}}